Integrative oncology in colorectal cancer: evidence-based strategies from prevention through survivorship - Summary - MDSpire

Integrative oncology in colorectal cancer: evidence-based strategies from prevention through survivorship

  • By

  • Cailu Shen

  • Rui Lou

  • Fan Bai

  • Ying Zhang

  • Tong Xu

  • Zebo Huang

  • June 26, 2026

  • 0 min

Share

Objective:

To synthesize current evidence across the full colorectal cancer (CRC) care continuum, from primary prevention through long-term survivorship, and to highlight integrative oncology strategies.

Approach:
  • Literature Review: A narrative review was conducted, examining dietary and lifestyle interventions, phytochemical and chemopreventive strategies, microbiome-targeted therapies, and mind-body practices in CRC care.
Key Findings:
  • High-fiber diets, Mediterranean dietary patterns, calcium supplementation, and regular physical activity are associated with CRC risk reduction.
  • The CHALLENGE trial provides evidence that structured exercise post-chemotherapy reduces disease recurrence and mortality in colon cancer.
  • Aspirin chemoprevention requires individualized risk-benefit assessment; preliminary data suggest low-dose aspirin may be non-inferior in Lynch syndrome.
  • Fusobacterium nucleatum promotes CRC through multiple molecular pathways.
  • Probiotics reduce postoperative complications, and fecal microbiota transplantation shows promise for sensitizing CRC to immunotherapy.
  • Mindfulness-based interventions, yoga, and acupuncture are endorsed for managing anxiety, depression, fatigue, and pain.
Interpretation:

Integrative oncology strategies are not consistently applied in routine CRC care despite the growing evidence base.

Limitations:
  • Integrative approaches remain inconsistently implemented in clinical practice.
  • The review did not apply a formal PRISMA process, which may affect the comprehensiveness of the literature search.
Conclusion:

A systematic integration of evidence-based interventions into CRC care is necessary, supported by standardized implementation frameworks and CRC-specific clinical trials.

Original Source(s)

Related Content